NANJING PANDA (00553) reported a net loss attributable to shareholders of RMB33.3201 million for the first three quarters, narrowing by 62.86% year-on-year.
Nanjing Panda Electronics (00553) announced its results for the first three quarters of 2026. The group recorded operating revenue of RMB2.129 billion, up 36.47% year-on-year; net loss attributable to shareholders of the listed company was RMB33.3201 million, narrowing by 62.86% year-on-year; basic earnings per share was -RMB0.0365.
NANJING PANDA (00553) announced its results for the first three quarters of 2026. The group recorded operating revenue of RMB2.129 billion, up 36.47% year-on-year; net loss attributable to shareholders of the listed company was RMB33.3201 million, narrowing by 62.86% year-on-year; basic loss per share was RMB0.0365.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process
Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares
CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process
Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares
CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
